avenacin A 1: an oat root saponin; RN refers to (3beta,4alpha,12beta,16beta,20beta,21beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 174808 |
| MeSH ID | M0241530 |
| Synonym |
|---|
| 90547-90-3 |
| avenacin a 1 |
| oleanan-29-al, 12,13-epoxy-3-((o-beta-d-glucopyranosyl-(1-2)-o-(beta-d-glucopyranosyl-(1-4))-alpha-l-arabinopyranosyl)oxy)-16,23-dihydroxy-21-((2-(methylamino)benzoyl)oxy)-, (3beta,4alpha,12beta,16beta,20beta,21beta)- |
| [21-formyl-17-hydroxy-9-[4-hydroxy-3,5-bis[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-10-(hydroxymethyl)-6,10,14,15,18,21-hexamethyl-2-oxahexacyclo[13.8.0.01,3.05,14.06,11.018,23]tricosan-20-yl] 2-(methylamino)benzoate |
| DTXSID801317812 |
| oleanan-29-al, 12,13-epoxy-3-[(o-beta-d-glucopyranosyl-(1-->2)-o-[beta-d-glucopyranosyl-(1-->4)]-alpha-l-arabinopyranosyl)oxy]-16,23-dihydroxy-21-[[2-(methylamino)benzoyl]oxy]-, (3beta,4alpha,12beta,16beta,20beta,21beta)- |
| AKOS040750645 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.40) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||